A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine.
- 1 June 1991
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 31 (6) , 643-647
- https://doi.org/10.1111/j.1365-2125.1991.tb05586.x
Abstract
1. The kinetics of codeine and metabolites were studied in eight unrelated healthy Chinese subjects following a single oral dose of 50 mg codeine phosphate. The data were compared with those from eight Caucasian subjects who were matched with the Chinese group according to their metabolic ratio (MR) of debrisoquine. 2. Mean values of Cmax (445 nmol l‐1) and AUC (1660 nmol l‐1 h) of codeine in the Chinese were significantly higher than those in the Caucasians (292 nmol l‐1 and 1010 nmol l‐1 h). Thus plasma clearance was significantly lower (P less than 0.02) and the plasma half‐life was longer (P less than 0.05) in the Chinese. 3. Partial clearance by glucuronidation was significantly lower (0.79 +/‐ 0.14 s.d. vs 1.42 +/‐ 0.48 s.d. 1 h‐1 kg‐1) in Chinese than in Caucasians. 4. The total urinary recovery of drug‐related material in 48 h urine was similar in Chinese (82.2%) and Caucasians (84.4%). The recovery of unchanged codeine was significantly higher in Chinese (5.7%) than in Caucasians (3.3%). 5. The AUC ratios of codeine relative to its 6‐glucuronide, morphine and norcodeine were 1:9, 35:1 and 4:1, respectively in Chinese. The corresponding ratios in Caucasians were 1:15, 50:1 and 6:1. 6. There was no significant difference between Chinese and Caucasians in the renal clearances of codeine and its primary metabolites. 7. Large interethnic differences in the kinetics of codeine have been shown. The Chinese are less able to metabolise codeine mainly because of a lower efficiency in glucuronidation.Keywords
This publication has 31 references indexed in Scilit:
- Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)Published by Elsevier ,2005
- Glucuronidation of Codeine and Morphine in Human Liver and Kidney Microsomes: Effect of InhibitorsBasic & Clinical Pharmacology & Toxicology, 1990
- DISASSOCIATION BETWEEN DEBRISOQUINE HYDROXYLATION PHENOTYPE AND GENOTYPE AMONG CHINESEThe Lancet, 1989
- Racial Differences in Drug ResponseNew England Journal of Medicine, 1989
- POLYMORPHIC O-DEMETHYLATION OF CODEINEThe Lancet, 1988
- ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDEThe Lancet, 1988
- Pharmacokinetics of Codeine After Single‐and Multiple‐Oral‐Dose Administration to Normal VolunteersThe Journal of Clinical Pharmacology, 1987
- LOW FREQUENCY OF SLOW DEBRISOQUINE HYDROXYLATION IN A NATIVE CHINESE POPULATIONThe Lancet, 1987
- Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and OrientalsCanadian Journal of Physiology and Pharmacology, 1980
- Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detectionJournal of Chromatography A, 1977